Moreover, in a clinical study of chronic lymphocytic leukemia (CLL), the expression of CD59 but not CD55 significantly increased in patients who failed to clear CLL cells from circulation after rituximab treatment (19). Here, CD55 is linked to B-cell chronic lymphocytic leukemia.